Novo Nordisk A/S (NVO)
NYSE • NVO • US6701002056
41.09Last close
Market Closed
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 3.7 days to cover, cost to borrow 0.37%. Sign up for live short interest data.
Market Cap
180b USD | # 104 in US
Volume
12.22m shares | 513.91m USD
Shares Outstanding
3.35t
Free Float Shares
94.66% | 3.17t